Login
$MGTX
$9.40 +$0.22 (2.4%) Close

$MGTX 4 SEC Filings

Filed On Filing
20 Oct 2026 Form 4: Giroux Richard, CFO & COO

Sold 56,000 shares ($557K)

06 Oct 2026 Form 4: Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY

Sold 27,659 shares ($294K)

24 Sep 2026 Form 4: Sebulsky Alan, Director

Granted 100,000 Restricted Share Units

18 Aug 2026 Form 4: Forbes Alexandria, Director

Sold 62,000 shares ($859K)

21 Jul 2026 Form 4: Giroux Richard, CFO & COO

Sold 56,000 shares ($701K)

07 Jul 2026 Form 4: Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY

Sold 27,659 shares ($409K)

29 Jun 2026 Form 4: Forbes Alexandria, Director

Granted 980,000 Restricted Share Units

29 Jun 2026 Form 4: Wollin Robert J, GENERAL COUNSEL AND SECRETARY

Granted 100,000 Restricted Share Units

29 Jun 2026 Form 4: Zeldin Robert K, CHIEF MEDICAL OFFICER

Granted 100,000 Restricted Share Units

29 Jun 2026 Form 4: Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY

Granted 70,000 Restricted Share Units

29 Jun 2026 Form 4: Giroux Richard, CFO & COO

Granted 980,000 Restricted Share Units

15 Jun 2026 Form 4: Harris Keith R., Director

Granted 106,441 Restricted Share Units

15 Jun 2026 Form 4: Yu Debra, Director

Granted 60,000 Restricted Share Units

15 Jun 2026 Form 4: Shenk Thomas E, Director

Granted 69,662 Restricted Share Units

15 Jun 2026 Form 4: Seligman Nicole, Director

Granted 60,000 Restricted Share Units

15 Jun 2026 Form 4: Mendoza Neil, Director

Granted 66,641 Restricted Share Units

15 Jun 2026 Form 4: Hukkelhoven Ellen, Director

Granted 60,000 Restricted Share Units

15 Jun 2026 Form 4: Perceptive Advisors Llc, Director and 2 others

Granted 60,000 Restricted Share Units

10 Jun 2026 Form 4: Harris Keith R., Director

Received 75,000 shares by exercise or conversion

28 May 2026 Form 4: Giroux Richard, CFO & COO

Gave 7,000 shares as a gift

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support